ITI News Archive
Stanford Medicine News
Stanford marks 1,000th heart-lung and lung transplant
Alicia Bland, who suffered from lung disease for three decades, got new lungs and “a second chance at life.”…
Three elected to National Academy of Medicine
Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.
Antibody treatment for peanut allergy
A Stanford-led pilot study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.
Cure for common cold in sight?
Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases, according to researchers at Stanford and UCSF.
Gut bugs influence flu vaccine response
Decimating levels of intestinal bacteria with antibiotics reduced the immune system’s responsiveness to a seasonal influenza vaccination, a Stanford-led study found.
Microbiome initiative launched
The Stanford Microbiome Therapies Initiative is backed by gifts from Marc and Lynne Benioff and Mark and Debra Leslie and is focused on developing and testing new disease therapies.
Tiny microbial proteins may affect human health
The bacteria in and on our bodies make thousands of tiny, previously unidentified proteins that could shed light on human health and advance drug development, Stanford researchers have found.
Forgotten immune cells slow MS in mice
Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.
Immune cells speed aging brains’ demise
Stanford researchers have found intrusive immune cells in a place in the brains of humans and older mice where new nerve cells are born. The intruders appear to impair nerve cell generation.
Calming immune cells to treat stroke in mice
Instead of trying to fix stroke-damaged nerve cells, Stanford scientists took aim at a set of first-responder immune cells that live outside the brain but rush to the site of a stroke. It worked.